Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer

The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2000-07, Vol.118 (1), p.129-137
Hauptverfasser: Schroen, Anneke T., Detterbeck, Frank C., Crawford, Robert, Rivera, M. Patricia, Socinski, Mark A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 1
container_start_page 129
container_title Chest
container_volume 118
creator Schroen, Anneke T.
Detterbeck, Frank C.
Crawford, Robert
Rivera, M. Patricia
Socinski, Mark A.
description The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC. Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns. Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians. Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing < 10 lung cancer patients annually than those who were seeing > 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing < 10 lung cancer patients annually rather than > 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents. Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.
doi_str_mv 10.1378/chest.118.1.129
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71232429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369215390139</els_id><sourcerecordid>71232429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</originalsourceid><addsrcrecordid>eNp1kd-L1DAQx4Mo3nr67JsEkXvrXtK0-fG4t3gqLCp4Poc0nW5zdJs1aRX_e8ftwh2CLxnCfOY7X75DyGvO1lwofe17yNOac73ma16aJ2TFjeCFqCvxlKwY42UhpCkvyIuc7xn-uZHPyQVn2gih2IoMNzAE6DLdHOK4p1_nAWsc4j7kKVM3tvSuj8n54Om3Oe0hjpmGkU49YAOSO8I8YW9zPKbofE-nSD_HscgHNwx0C_jsZtTdutFDekmedW7I8OpcL8n32_d324_F7suHT9vNrvCVMFNRa6arrla1ZJU0jWqkBKOYa7RW2lRM1VqWqmrahrGu9pqXdavASJBKdUYLcUmuFl009WPGhOwhZI9m3AhxzlbxUpRVaRB8-w94H-c0ojdbMlYpXCgRul4gn2LOCTp7TOHg0m_Lmf17BXu6gsUrWG75SfbNWXZuDtA-4pfYEXh3Blz2bugSxhPyA1cJKQV72NyHff8rJLCnXFFVLDvPbh9vNssEYLw_AySbfQDMvsVpP9k2hv-6_gOxZ7Nq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200478876</pqid></control><display><type>article</type><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</creator><creatorcontrib>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</creatorcontrib><description>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC. Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns. Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians. Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing &lt; 10 lung cancer patients annually than those who were seeing &gt; 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing &lt; 10 lung cancer patients annually rather than &gt; 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents. Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.118.1.129</identifier><identifier>PMID: 10893370</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Attitude of Health Personnel ; attitudes ; Biological and medical sciences ; carcinoma ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - surgery ; Carcinoma, Non-Small-Cell Lung - therapy ; clinical practice patterns ; Combined Modality Therapy ; Female ; Humans ; Lung cancer ; Lung Neoplasms - mortality ; Lung Neoplasms - surgery ; Lung Neoplasms - therapy ; Male ; Medical sciences ; Middle Aged ; non-small cell physician knowledge ; physician surveys ; practice ; Practice Patterns, Physicians ; Pulmonary Medicine ; Referral and Consultation ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the respiratory system ; Thoracic Surgery</subject><ispartof>Chest, 2000-07, Vol.118 (1), p.129-137</ispartof><rights>2000 The American College of Chest Physicians</rights><rights>2000 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Jul 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</citedby><cites>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1436630$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10893370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schroen, Anneke T.</creatorcontrib><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Crawford, Robert</creatorcontrib><creatorcontrib>Rivera, M. Patricia</creatorcontrib><creatorcontrib>Socinski, Mark A.</creatorcontrib><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><title>Chest</title><addtitle>Chest</addtitle><description>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC. Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns. Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians. Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing &lt; 10 lung cancer patients annually than those who were seeing &gt; 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing &lt; 10 lung cancer patients annually rather than &gt; 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents. Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</description><subject>Adult</subject><subject>Attitude of Health Personnel</subject><subject>attitudes</subject><subject>Biological and medical sciences</subject><subject>carcinoma</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>clinical practice patterns</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - surgery</subject><subject>Lung Neoplasms - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>non-small cell physician knowledge</subject><subject>physician surveys</subject><subject>practice</subject><subject>Practice Patterns, Physicians</subject><subject>Pulmonary Medicine</subject><subject>Referral and Consultation</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the respiratory system</subject><subject>Thoracic Surgery</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kd-L1DAQx4Mo3nr67JsEkXvrXtK0-fG4t3gqLCp4Poc0nW5zdJs1aRX_e8ftwh2CLxnCfOY7X75DyGvO1lwofe17yNOac73ma16aJ2TFjeCFqCvxlKwY42UhpCkvyIuc7xn-uZHPyQVn2gih2IoMNzAE6DLdHOK4p1_nAWsc4j7kKVM3tvSuj8n54Om3Oe0hjpmGkU49YAOSO8I8YW9zPKbofE-nSD_HscgHNwx0C_jsZtTdutFDekmedW7I8OpcL8n32_d324_F7suHT9vNrvCVMFNRa6arrla1ZJU0jWqkBKOYa7RW2lRM1VqWqmrahrGu9pqXdavASJBKdUYLcUmuFl009WPGhOwhZI9m3AhxzlbxUpRVaRB8-w94H-c0ojdbMlYpXCgRul4gn2LOCTp7TOHg0m_Lmf17BXu6gsUrWG75SfbNWXZuDtA-4pfYEXh3Blz2bugSxhPyA1cJKQV72NyHff8rJLCnXFFVLDvPbh9vNssEYLw_AySbfQDMvsVpP9k2hv-6_gOxZ7Nq</recordid><startdate>20000701</startdate><enddate>20000701</enddate><creator>Schroen, Anneke T.</creator><creator>Detterbeck, Frank C.</creator><creator>Crawford, Robert</creator><creator>Rivera, M. Patricia</creator><creator>Socinski, Mark A.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20000701</creationdate><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><author>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Attitude of Health Personnel</topic><topic>attitudes</topic><topic>Biological and medical sciences</topic><topic>carcinoma</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>clinical practice patterns</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - surgery</topic><topic>Lung Neoplasms - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>non-small cell physician knowledge</topic><topic>physician surveys</topic><topic>practice</topic><topic>Practice Patterns, Physicians</topic><topic>Pulmonary Medicine</topic><topic>Referral and Consultation</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the respiratory system</topic><topic>Thoracic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schroen, Anneke T.</creatorcontrib><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Crawford, Robert</creatorcontrib><creatorcontrib>Rivera, M. Patricia</creatorcontrib><creatorcontrib>Socinski, Mark A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schroen, Anneke T.</au><au>Detterbeck, Frank C.</au><au>Crawford, Robert</au><au>Rivera, M. Patricia</au><au>Socinski, Mark A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2000-07-01</date><risdate>2000</risdate><volume>118</volume><issue>1</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC. Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns. Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians. Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing &lt; 10 lung cancer patients annually than those who were seeing &gt; 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing &lt; 10 lung cancer patients annually rather than &gt; 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents. Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>10893370</pmid><doi>10.1378/chest.118.1.129</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2000-07, Vol.118 (1), p.129-137
issn 0012-3692
1931-3543
language eng
recordid cdi_proquest_miscellaneous_71232429
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Attitude of Health Personnel
attitudes
Biological and medical sciences
carcinoma
Carcinoma, Non-Small-Cell Lung - mortality
Carcinoma, Non-Small-Cell Lung - surgery
Carcinoma, Non-Small-Cell Lung - therapy
clinical practice patterns
Combined Modality Therapy
Female
Humans
Lung cancer
Lung Neoplasms - mortality
Lung Neoplasms - surgery
Lung Neoplasms - therapy
Male
Medical sciences
Middle Aged
non-small cell physician knowledge
physician surveys
practice
Practice Patterns, Physicians
Pulmonary Medicine
Referral and Consultation
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the respiratory system
Thoracic Surgery
title Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beliefs%20Among%20Pulmonologists%20and%20Thoracic%20Surgeons%20in%20the%20Therapeutic%20Approach%20to%20Non-small%20Cell%20Lung%20Cancer&rft.jtitle=Chest&rft.au=Schroen,%20Anneke%20T.&rft.date=2000-07-01&rft.volume=118&rft.issue=1&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.118.1.129&rft_dat=%3Cproquest_cross%3E71232429%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200478876&rft_id=info:pmid/10893370&rft_els_id=S0012369215390139&rfr_iscdi=true